IGHE and atopic asthma: Among them, IL-4 and IL-13-mediated severe atopic asthma with elevated serum IgE and periostin can be treated effectively with an anti-IgE monoclonal antibody, omalizumab, or an anti-IL-13 monoclonal antibody, lebrikizumab [33-36].